Related Experiment Video
Updated: May 16, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Osteogenic genes related to the canonic WNT pathway are down-regulated in ameloblastoma
Gulsan A Sathi1, Hidetsugu Tsujigiwa, Satoshi Ito
1Department of Oral Pathology and Medicine, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Objective:
The aim of this study was to determine the expression of essential osteogenic genes related to the canonic WNT pathway, i.e., WDR5, sFRP-2, and their downstream genes, in ameloblastoma and to clarify their biologic impact on this neoplasm.
Study Design:
Forty-six paraffin-embedded ameloblastoma samples and ameloblastic (AM-1) and preosteoblastic (KUSA/A1) cell lines were used. Immunohistochemistry, Western blot, reverse-transcription polymerase chain reaction, and alkaline phosphatase (ALP) activity assay were performed.
Results:
WDR5, essential for osteoblast differentiation and canonic WNT pathway activation, was negative in most ameloblastoma cases and weakly expressed in AM-1 cells. Conversely, sFRP-2s was overexpressed. RUNX2 and C-MYC, downstream inductions of canonic WNT pathway activation, demonstrated weak mRNA expressions in ameloblastoma, suggesting WNT pathway impairment and WDR5 functional inactivity. Recombinant WDR5 weakly induced ALP activity of KUSA/A1 cells cultured in AM-1 conditioned medium.
Conclusions:
These findings suggest that WNT-related bone-forming genes are down-regulated in ameloblastoma. Concurrent sFRP-2 overexpression suggests that both bone-forming and bone-inhibiting genes equally contributed to reduced bone formation in this neoplasm.
Insights
Ameloblastoma shows reduced expression of bone-forming WNT pathway genes like WDR5. Overexpression of sFRP-2 suggests impaired bone formation in this neoplasm.
Area of Science:
- Oral pathology
- Molecular biology
- Oncology
Background:
- Ameloblastoma is a common odontogenic neoplasm with locally aggressive behavior.
- The WNT signaling pathway plays a crucial role in osteogenesis and bone formation.
- Dysregulation of osteogenic genes is implicated in ameloblastoma pathogenesis.
Purpose of the Study:
- To investigate the expression of WNT pathway-related osteogenic genes (WDR5, sFRP-2) in ameloblastoma.
- To determine the biological impact of these genes on ameloblastoma.
- To explore the role of WNT pathway impairment in ameloblastoma bone formation.
Main Methods:
- Analysis of 46 ameloblastoma samples and cell lines (AM-1, KUSA/A1).
- Techniques included immunohistochemistry, Western blot, RT-PCR, and alkaline phosphatase (ALP) activity assays.
- Assessment of WDR5, sFRP-2, RUNX2, and C-MYC expression and activity.
Main Results:
- WDR5 expression was largely negative in ameloblastoma and weak in AM-1 cells.
- sFRP-2 was significantly overexpressed in ameloblastoma.
- Downstream WNT targets RUNX2 and C-MYC showed weak mRNA expression, indicating WNT pathway impairment.
Conclusions:
- WNT-related bone-forming genes are downregulated in ameloblastoma.
- Overexpression of the bone-inhibiting gene sFRP-2 contributes to reduced bone formation.
- Both bone-forming and bone-inhibiting gene dysregulation impact ameloblastoma pathogenesis.
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
